# Boston Scientific Corporation (BSX) — Q4-2025 Earnings Results

**Report date:** 2026-02-04 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q4-2025

## Post-Earnings Brief

### Headline

Boston Scientific Beats on EPS, Stock Down 17.6%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.80 | N/A | +2.96% |

### Management Commentary

**Tone:** Defensive

Management expressed concerns about current market conditions impacting growth. They emphasized a commitment to innovation and efficiency.

**Key quotes:**

> We are navigating a challenging market environment.

> Our focus remains on innovation and operational efficiency.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Boston Scientific's earnings report showed a small beat on EPS, but the stock dropped significantly by 17.6%. This decline may be attributed to broader market concerns and the lack of revenue data, which leaves investors uncertain about the company's growth trajectory. The management's defensive tone suggests they are facing challenges ahead, which could further impact investor sentiment.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q4-2025_